Home・Aktien・Compugen Ltd

Compugen Ltd

Geschlossen

1.91 -5.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.98

Max

2.04

Schlüsselkennzahlen
By Trading Economics
Einkommen	663K -7M
Verkäufe	426K 2.6M
KGV Branchendurchschnitt	5.211 51.78
EPS	-0.07
Gewinnspanne	-269.254
Angestellte	75
EBITDA	665K -7M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+123.88% upside

Dividenden
By Acuity
Nächstes Ergebnis	9. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-38M 188M
Vorheriger Eröffnungskurs	7.36
Vorheriger Schlusskurs	1.91

Compugen Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Nov. 2026, 23:56 UTC

KBR Inc shares are down significantly in after-market trading, falling to their lowest point of the day.

4. Nov. 2026, 23:56 UTC

News

Social Media

Trimble Inc appoints Matthew C. Brown, former CFO of Tenable Holdings, to its Board of Directors in after-market trading.

4. Nov. 2026, 23:56 UTC

Correlated Moves

D.R. Horton, Inc. shares traded modestly lower in after-market hours, while Amcor PLC's sharp decline followed disappointing Q1 results and lowered EPS guidance.

4. Nov. 2026, 23:56 UTC

Hims & Hers Health, Inc. is trading modestly higher in after-market hours following an increase during the session.

4. Nov. 2026, 23:56 UTC

Correlated Moves

Lattice Semiconductor Corporation shares declined in after-market trading, continuing a downward trend since Wednesday's close and nearing the lower end of their one-month range.

4. Nov. 2026, 23:56 UTC

IES Holdings Inc shares rose significantly during after-market hours on Wednesday, recovering from a recent decline and moving higher following the close of regular trading.

4. Nov. 2026, 23:56 UTC

Synopsys, Inc. shares are trading modestly higher in after-market hours, recovering from earlier lows after four consecutive daily declines.

4. Nov. 2026, 23:52 UTC

News

Uranium Energy Corp. is trading modestly higher in after-market hours following fluctuations since Wednesday's close.

4. Nov. 2026, 23:51 UTC

Kontoor Brands, Inc. is trading lower in after-market hours, retreating from a brief uptick and remaining at the lower end of its recent range.

4. Nov. 2026, 23:51 UTC

GE HealthCare Technologies Inc. is trading modestly higher in after-market hours, despite a slight decline from earlier session highs.

4. Nov. 2026, 23:51 UTC

Mondelez International, Inc. shares have advanced modestly in after-market hours, remaining near the upper end of their one-month range.

4. Nov. 2026, 23:51 UTC

Avient Corp is declining in after-market trading, falling to its lowest point of the day.

4. Nov. 2026, 23:51 UTC

Lindsay Corporation's shares traded modestly lower during after-market hours on Wednesday, remaining around the midpoint of their one-month trading range.

4. Nov. 2026, 23:51 UTC

News

Watts Water Technologies reports Q3 net sales of $728 million, exceeding estimates, with diluted EPS of $4.34 and raises full-year sales growth outlook to 17%-18%.

4. Nov. 2026, 23:51 UTC

Twist Bioscience Corporation shares declined during after-market hours on Wednesday, reversing a trend of higher daily closes observed in recent sessions.

4. Nov. 2026, 23:51 UTC

Wendy's Co shares are declining in after-market trading, reflecting pronounced losses despite a strong recent performance and seven consecutive sessions of higher closes.

4. Nov. 2026, 23:51 UTC

Delta Air Lines, Inc. shares are trading lower in after-market hours, pulling back from earlier gains.

4. Nov. 2026, 23:51 UTC

Correlated Moves

Clorox Company shares are modestly lower in after-market trading, following a brief peak earlier in the session.

4. Nov. 2026, 23:51 UTC

BlackRock, Inc. shares traded modestly lower in after-market hours, retracing from an early session peak.

4. Nov. 2026, 23:51 UTC

Correlated Moves

Vertiv Holdings Co is modestly higher in after-market trading, moving in sympathy with Eaton Corporation PLC following strong third-quarter results.

4. Nov. 2026, 23:51 UTC

Redwood Trust, Inc. shares declined during after-market trading on Wednesday, moving notably lower from a modest high shortly after the market closed.

4. Nov. 2026, 23:46 UTC

News

Correlated Moves

Chord Energy reports Q3 adjusted EPS of $6.08, exceeding estimates, while revenues of $1.71B missed expectations; raises 2026 adjusted EBITDA guidance to $3.4B.

4. Nov. 2026, 23:46 UTC

Martin Marietta Materials, Inc. is trading modestly higher in after-market hours, reaching its highest level since Wednesday's close and above its 20-day moving average.

4. Nov. 2026, 23:46 UTC

ZIM Integrated Shipping Services Ltd is trading lower in after-market hours, continuing its downward trend from Wednesday's close and positioned 3.49% below its 20-day moving average.

4. Nov. 2026, 23:46 UTC

News

UBS maintains Neutral rating on Coca-Cola Europacific Partners PLC and raises price target to $115 in a report published after the market closed.

4. Nov. 2026, 23:46 UTC

The NZD/CAD is trading modestly higher, supported by stronger-than-expected ADP Employment Change data, which reported an increase of 86k jobs in October.

4. Nov. 2026, 23:46 UTC

GBP/NZD is lower, reflecting a decline since Tuesday's close.S. employment and services data.

4. Nov. 2026, 23:46 UTC

Arbor Realty Trust, Inc. traded roughly flat in after-market hours, remaining near the lower end of its one-month range and below its 20-day moving average.

4. Nov. 2026, 23:42 UTC

Lincoln Electric Holdings, Inc. is trading lower in after-market hours, reversing an initial gain and marking a fourth consecutive daily decline.

4. Nov. 2026, 23:42 UTC

Alector, Inc. is declining sharply in after-market trading, reaching its lowest point of the day after previously showing strength above its 20-day moving average.

Peer-Vergleich

Kursveränderung

Compugen Ltd Prognose

Kursziel

By TipRanks

123.88% Vorteil

12-Monats-Prognose

Durchschnitt 4.5 USD 123.88%

Hoch 6 USD

Tief 4 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Compugen Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Compugen Ltd – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.